SciELO - Scientific Electronic Library Online

 
vol.84 número3Identificación del virus de hepatitis delta genotipo 3 en comunidades andinas y amazónicas del Perú índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Anales de la Facultad de Medicina

versión impresa ISSN 1025-5583

Resumen

VARGAS-HERRERA, Natalia  y  SANCHEZ, Juan F.. Association between fear of COVID-19 and adherence to antiretroviral treatment in people with HIV-AIDS. An. Fac. med. [online]. 2023, vol.84, n.3, pp.235-241.  Epub 30-Sep-2023. ISSN 1025-5583.  http://dx.doi.org/10.15381/anales.v84i3.25254.

Introduction.

One of the most frequent psychological consequences of COVID-19 is fear, which could lead to non-optimal therapeutic adherence and, therefore, to the disease progression.

Objectives.

To evaluate the possible association between the fear of contracting COVID-19 and adherence to antiretroviral therapy in persons with HIV during the period between the third and fourth epidemic wave of COVID-19 in Peru.

Methods.

Analytical cross-sectional study in adults with HIV from the specialized center “Vía Libre” enrolled by non-probabilistic sampling. The validated “Fear of COVID-19 Scale” was used to measure the fear of getting sick from COVID-19, and the “SMAQ” questionnaire to assess therapeutic adherence. Results were presented descriptively, using chi-square for bivariate analysis and generalized linear models, Poisson family to calculate crude and adjusted prevalence ratios (aPR).

Results.

Between February and July of 2022, 149 adults with a median age of 35 years were enrolled, 91.3% being male, and 75,2% had undetectable viral load levels. No association was found between fear of contracting COVID-19 and HAART adherence (aPR: 0,99; 95% CI 0,97 to 1,02). Persons with a comorbidity were 89% more adherent than persons withoutcomorbidities (RPa: 1,89; 95% CI 1,52 to 2,35).

Conclusion.

The fear of contracting COVID-19 was not associated with adherence to HAART during the third wave of COVID-19 pandemic in Peru. However, presenting a comorbidity was associated with optimal HAART adherence. Emphasis should be placed on potential factors affecting medication adherence in people with HIV during the COVID-19 pandemic.

Palabras clave : COVID-19; Fear; Treatment Adherence and Compliance; Highly Active Antiretroviral Therapy; HIV Infections.

        · resumen en Español     · texto en Español     · Español ( pdf )